Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|January 18, 2014
Foundation-directed therapeutic development in Huntington's diseaseCelia Dominguez, Ignacio Munoz-Sanjuan
Current Medicinal Chemistry|December 28, 2005
MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha proteinMatthew R Lee, Celia Dominguez
Current Opinion in Drug Discovery & Development|July 19, 2005
p38 MAP kinase inhibitors: many are made, but few are chosenCelia Dominguez, David A Powers, Nuria Tamayo
Annals of the New York Academy of Sciences|June 25, 2008
Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile x-associated primary ovarian insufficiencyJohn J De Caro, Celia Dominguez, Stephanie L Sherman
Translational Research : the Journal of Laboratory and Clinical Medicine|June 26, 2012
Antioxidant supplementation reduces endometriosis-related pelvic pain in humansNalini Santanam, Nino Kavtaradze, Ana Murphy, et al.
The Journal of Organic Chemistry|November 19, 2005
A soluble base for the copper-catalyzed imidazole N-arylations with aryl halidesLongbin Liu, Mike Frohn, Ning Xi, et al.
Bioorganic & Medicinal Chemistry Letters|August 9, 2011
Structure of human caspase-6 in complex with Z-VAD-FMK: New peptide binding mode observed for the non-canonical caspase conformationIlka Müller, Marieke B A C Lamers, Alison J Ritchie, et al.
Life Science Alliance|August 8, 2023
IKBKB reduces huntingtin aggregation by phosphorylating serine 13 via a non-canonical IKK pathwayCristina Cariulo, Paola Martufi, Margherita Verani, et al.
Journal of Biomolecular Screening|May 22, 2013
Development of LC/MS/MS, high-throughput enzymatic and cellular assays for the characterization of compounds that inhibit kynurenine monooxygenase (KMO)Dirk Winkler, Maria Beconi, Leticia M Toledo-Sherman, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 9, 2021
Pharmacokinetics and metabolic disposition of a potent and selective kynurenine monooxygenase inhibitor, CHDI-340246, in laboratory animalsVinod Khetarpal, Todd Herbst, Diana Shefchek, et al.
Pageof 9